Medical device recalls Moderate risk

RAYSEARCH LABORATORIES AB recalls RayStation Product Usage: is a software system designed for treatment planning and analysis of radiation therapy. The t…

Recall date
July 17, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0380-2018
FDA classification
Class II
Brand / firm
RAYSEARCH LABORATORIES AB
Sold / distributed
US Nationwide Distribution - FL, WA, AZ, TN, MD, TX, FL, MI, Washington D.C.

Why it was recalled

For the proton QA preparation module in RayStation 6 (including SP1 and SP2), if the snout position or gap is modified in the QA module, the dose in the QA module may be computed for a different setup than what is used for QA measurements. This could result in an incorrect dosage being provided to a patient.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

RayStation Product Usage: is a software system designed for treatment planning and analysis of radiation therapy. The treatment plans provide treatment unit set-up parameters and estimates of dose distributions expected during the proposed treatment, and may be used to administer treatments after review and approval by the intended user.

Get recall alerts

Free email alert whenever RAYSEARCH LABORATORIES AB has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: RAYSEARCH LABORATORIES AB